Cite

HARVARD Citation

    Baxter-Holland, M. et al. (2018). Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use. Journal of pharmacy and pharmacology. pp. 320-327. [Online]. 
  
Back to record